# Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

> **NCT04654325** · NA · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 534 (actual)

## Conditions studied

- SARS-CoV-2

## Interventions

- **DIAGNOSTIC_TEST:** conjunctival swab

## Key facts

- **NCT ID:** NCT04654325
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-19
- **Primary completion:** 2021-04-29
- **Final completion:** 2021-04-29
- **Target enrollment:** 534 (ACTUAL)
- **Why stopped:** less covid testing
- **Last updated:** 2022-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654325, "Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04654325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*